Section Arrow
ASRT.NASDAQ
- Assertio Holdings Inc.
Quotes are at least 15-min delayed:2026/03/29 03:47 EDT
Regular Hours
Last
 19.39
-0.14 (-0.72%)
Day High 
19.88 
Prev. Close
19.53 
1-M High
20.45 
Volume 
161.59K 
Bid
19.05
Ask
19.4
Day Low
18.71 
Open
19.31 
1-M Low
11.05 
Market Cap 
125.32M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 14.52 
20-SMA 13.13 
50-SMA 12.35 
52-W High 20.45 
52-W Low 7.7055 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.32/4.15
Enterprise Value
165.33M
Balance Sheet
Book Value Per Share
14.58
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
118.71M
Operating Revenue Per Share
26.18
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.38-1.48-7.09%40.92PE
HLNHaleon plc9.8+0.05+0.51%19.79PE
TEVATeva Pharmaceutical Industries Limited28.74-1.04-3.49%24.64PE
ELANElanco Animal Health23.13-1.45-5.90%355.43PE
VTRSViatris13.05-0.32-2.39%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild tomoderate pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.